Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (101-110 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Rheumatology|August 1, 1989
Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritisD O Clegg, D E Furst, K G Tolman, et al.
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Contemporary Clinical Trials|September 16, 2010
Handling missing data issues in clinical trials for rheumatic diseasesWeng Kee Wong, W J Boscardin, A E Postlethwaite, et al.
Lupus|January 12, 2018
Secular trends in the impact factors of SLE publications over a 45-year period-a systematic reviewN Cohen, M Mimouni, M M Glatstein, et al.
Journal of Clinical Pharmacology|July 1, 1983
Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteersD E Furst, S H Dromgoole, R K Desiraju, et al.
The Journal of Rheumatology|March 1, 1989
Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritisD E Furst, R Koehnke, L F Burmeister, et al.
Arthritis and Rheumatism|August 1, 1979
A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?D E Furst, P J Clements, P Graze, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Glucocorticoids in the treatment of early and late RAJ W J Bijlsma, M Boers, K G Saag, et al.
The Journal of Rheumatology|March 1, 1996
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritisJ M Kremer, D E Furst, M E Weinblatt, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Building towards a consensus for the use of tumour necrosis factor blocking agentsD E Furst, F C Breedveld, J R Kalden, et al.
Pageof 26

Showing results (101-110 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|August 1, 1989
Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritisD O Clegg, D E Furst, K G Tolman, et al.
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Contemporary Clinical Trials|September 16, 2010
Handling missing data issues in clinical trials for rheumatic diseasesWeng Kee Wong, W J Boscardin, A E Postlethwaite, et al.
Lupus|January 12, 2018
Secular trends in the impact factors of SLE publications over a 45-year period-a systematic reviewN Cohen, M Mimouni, M M Glatstein, et al.
Journal of Clinical Pharmacology|July 1, 1983
Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteersD E Furst, S H Dromgoole, R K Desiraju, et al.
The Journal of Rheumatology|March 1, 1989
Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritisD E Furst, R Koehnke, L F Burmeister, et al.
Arthritis and Rheumatism|August 1, 1979
A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?D E Furst, P J Clements, P Graze, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Glucocorticoids in the treatment of early and late RAJ W J Bijlsma, M Boers, K G Saag, et al.
The Journal of Rheumatology|March 1, 1996
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritisJ M Kremer, D E Furst, M E Weinblatt, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Building towards a consensus for the use of tumour necrosis factor blocking agentsD E Furst, F C Breedveld, J R Kalden, et al.
Pageof 26